Lytix Biopharma ASA (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 10.55
-0.05 (-0.47%)
May 13, 2026, 4:11 PM CET
Lytix Biopharma ASA Market Cap
Lytix Biopharma ASA has a market cap or net worth of 811.3 million as of May 14, 2026. Its market cap has increased by 119.28% in one year.
Market Cap
811.30M
Enterprise Value
741.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.55
Market Cap Chart
Since June 14, 2021, Lytix Biopharma ASA's market cap has increased from 720.55M to 811.30M, an increase of 12.59%. That is a compound annual growth rate of 2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 811.30M | 20.29% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.79B |
| Thor Medical ASA | 1.62B |
| ArcticZymes Technologies ASA | 1.04B |
| Nykode Therapeutics AS | 1.01B |
| Zelluna ASA | 556.92M |
| SoftOx Solutions AS | 298.98M |
| Oncoinvent ASA | 212.28M |
| Arctic Bioscience AS | 88.96M |